Rnjms /Id# 162213 — Newark, New Jersey

Rnjms /Id# 162213 is a clinical research site located in Newark, New Jersey, United States 07103.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rnjms /Id# 162213 has participated in 1 clinical trials.

Therapeutic areas: Hepatitis C Virus (HCV).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rnjms /Id# 162213?

Rnjms /Id# 162213 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rnjms /Id# 162213 conducted?

Rnjms /Id# 162213 has 1 clinical trials on record. Their work covers Hepatitis C Virus (HCV).

Is Rnjms /Id# 162213 accredited by Crixeo Health?

Rnjms /Id# 162213 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rnjms /Id# 162213?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.